INmune Bio

$8.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.44 (+5.51%) Today
+$0.18 (+2.14%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell INmune Bio and other stocks, options, and ETFs commission-free!

About INMB

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. Read More The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA. The listed name for INMB is INmune Bio Inc. Common stock.

Employees
4
Headquarters
La Jolla, California
Founded
2015
Market Cap
113.23M
Price-Earnings Ratio
Dividend Yield
Average Volume
163.99K
High Today
$8.45
Low Today
$7.97
Open Price
$7.97
Volume
72.31K
52 Week High
$24.42
52 Week Low
$2.20

Collections

INMB Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 6, After Hours

You May Also Like